Aug 13, 2026 09:31AM
Aug 13, 2026 09:30AM
Aug 6, 2026 11:34AM
Aug 6, 2026 11:29AM
Jul 22, 2026 08:30AM
Jul 6, 2026 08:45AM
Jun 29, 2026 09:30AM NeuroSense ALS drug meets Phase 2b primary endpoint in TDP-43 trial
Jun 29, 2026 09:30AM
Jun 25, 2026 09:20AM
Jun 25, 2026 09:20AM
Jun 22, 2026 09:00AM
Jun 11, 2026 09:02AM
Jun 11, 2026 09:00AM
Jun 9, 2026 09:01AM NeuroSense receives Japanese patent for ALS drug candidate PrimeC
Jun 9, 2026 09:00AM
Apr 6, 2026 09:20AM
Apr 6, 2026 09:20AM
Mar 31, 2026 09:20AM
Mar 24, 2026 09:03AM
Mar 24, 2026 09:00AM
Mar 18, 2026 08:00AM PrimeC New Data to Be Presented at AD/PD™ 2026 Conference
Mar 16, 2026 11:34AM
Mar 16, 2026 11:33AM
Mar 9, 2026 11:07AM
Feb 18, 2026 09:05AM
Feb 18, 2026 09:05AM
Feb 9, 2026 09:20AM
Feb 9, 2026 09:20AM NeuroSense Expands Global IP Protection Strategy With Granted Australian Patent Covering PrimeC Composition
Jan 21, 2026 08:30AM
Jan 21, 2026 08:30AM
Jan 8, 2026 08:45AM
Dec 22, 2025 09:18AM
Dec 22, 2025 09:17AM
Dec 4, 2025 07:30AM
Nov 24, 2025 09:56AM NeuroSense gets FDA clearance for phase 3 ALS drug trial
Nov 24, 2025 09:56AM
Oct 6, 2025 09:00AM
Sep 10, 2025 02:30PM
Sep 4, 2025 08:49AM
Sep 4, 2025 08:49AM
Aug 1, 2025 09:00AM
Jul 22, 2025 08:42AM Award-Winning Broadway, Television & Film Star Aaron Lazar Featuring NeuroSense CEO Alon Ben-Noon in a Special Live Podcast on ALS Science, PrimeC's Commercialization Strategies, and Community
Apr 24, 2025 09:09AM
Apr 24, 2025 09:09AM
Apr 9, 2025 08:30AM
Apr 9, 2025 08:30AM
Apr 7, 2025 05:14PM
Apr 4, 2025 09:10AM
Mar 20, 2025 10:30AM Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug
Mar 17, 2025 08:30AM

329,957 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All